BioNTech SE (BNTX) Reports Q2 Loss of $0.38

Go back to BioNTech SE (BNTX) Reports Q2 Loss of $0.38

BioNTech (BNTX) PT Raised to $62 at SVB Leerink

August 7, 2020 5:39 AM EDT

SVB Leerink analyst Daina Graybosch raised the price target on BioNTech (NASDAQ: BNTX) to $62.00 (from $42.00) while maintaining a Market Perform rating.... More